Pulmonology Book

//fpnotebook.com/

Asthmanefrin

Aka: Asthmanefrin, Racepinephrine
  1. Background
    1. Over-the-counter Racemic EpinephrineInhaler used by patients for self-diagnosed bronchospasm
    2. Replaces Primatene Mist
      1. Removed from U.S. market in 2011 due to chlorofluorocarbons
      2. Editorial comment: I thought it was removed for the other right reason (it is dangerous)
  2. Disadvantages: Compared with prescribed AlbuterolInhaler
    1. OTC status bypasses Asthma Evaluation and assessment for controller medications (CorticosteroidInhalers)
    2. Shorter-acting and less effective than Albuterol
    3. Increased side effects and more rebound symptoms than Albuterol
    4. Significant set-up and maintenance of delivery device
    5. More expensive than Albuterol
  3. References
    1. (2012) Presc Lett 19(10): 58
    2. Dickinson (2000) Chest 118:522–526 [PubMed]

You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree